UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oral delivery of anticancer drugs: Challenges and opportunities

Journal of controlled release, 2013-08, Vol.170 (1), p.15-40

2013

Volltextzugriff (PDF)

A PPAR-β/δ agonist is neuroprotective and decreases cognitive impairment in a rodent model of Parkinson's disease

Current neurovascular research, 2014-05, Vol.11 (2), p.114-124

2014

Volltextzugriff (PDF)

p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies

Current topics in medicinal chemistry, 2013-05, Vol.13 (9), p.1015-1035

2013

Volltextzugriff (PDF)

Neuroprotective Potential of Peroxisome Proliferator Activated Receptor-α Agonist in Cognitive Impairment in Parkinson's Disease: Behavioral, Biochemical, and PBPK Profile

PPAR Research, 2014-01, Vol.2014 (2014), p.243-251

2014

Volltextzugriff (PDF)

Oleanolic acid analogs as NO, TNF-α and IL-1β inhibitors: Synthesis, biological evaluation and docking studies

Bioorganic & medicinal chemistry letters, 2014-09, Vol.24 (17), p.4114-4119

2014

Volltextzugriff (PDF)

Characterization of degradation products of Ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis

Journal of mass spectrometry., 2015-02, Vol.50 (2), p.344-353

2015

Volltextzugriff (PDF)

Leucine-684: A conserved residue of an AMP-acetyl CoA synthetase (AceCS) from Leishmania donovani is involved in substrate recognition, catalysis and acetylation

Gene, 2016-04, Vol.580 (2), p.125-133

2016

Volltextzugriff (PDF)

A combined ligand and structure based approach to design potent PPAR-alpha agonists

Journal of molecular structure, 2012-11, Vol.1028, p.22-30

2012

Volltextzugriff (PDF)

Effect of Different “States” of Sorbed Water on Amorphous Celecoxib

Journal of pharmaceutical sciences, 2014-07, Vol.103 (7), p.2033-2041

2014

Volltextzugriff (PDF)

A combined pharmacophore modeling, 3D-QSAR and molecular docking study of substituted bicyclo-[3.3.0]oct-2-enes as liver receptor homolog-1 (LRH-1) agonists

Journal of molecular structure, 2013-10, Vol.1049, p.315-325

2013

Volltextzugriff (PDF)

Identification of p38α MAP kinase inhibitors by pharmacophore based virtual screening

Journal of molecular graphics & modelling, 2014-04, Vol.49, p.18-24

2014

Volltextzugriff (PDF)

Biological evaluation and structural insights for design of subtype-selective peroxisome proliferator activated receptor-α (PPAR-α) agonists

Bioorganic & medicinal chemistry letters, 2015-01, Vol.25 (2), p.270-275

2015

Volltextzugriff (PDF)

Antiplasmodial activity of short peptide-based compounds

RSC advances, 2015-01, Vol.5 (29), p.22674-22684

2015

Volltextzugriff (PDF)

Identification of dual Acetyl-CoA carboxylases 1 and 2 inhibitors by pharmacophore based virtual screening and molecular docking approach

Molecular diversity, 2013-02, Vol.17 (1), p.139-149

2013

Volltextzugriff (PDF)

Structure based virtual screening to identify selective phosphodiesterase 4B inhibitors

Journal of molecular graphics & modelling, 2015-04, Vol.57, p.89-98

2015

Volltextzugriff (PDF)

IPAT: a freely accessible software tool for analyzing multiple patent documents with inbuilt landscape visualizer

Pharmaceutical patent analyst, 2015-01, Vol.4 (5), p.377-386

2015

Volltextzugriff (PDF)

3D QSAR pharmacophore-based virtual screening and molecular docking studies to identify novel matrix metalloproteinase 12 inhibitors

Molecular simulation, 2013-04, Vol.39 (5), p.385-396

2013

Volltextzugriff (PDF)

Characterization of degradation products of Ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H sub(2)SO sub(4) acid hydrolysis

Journal of mass spectrometry., 2015-02, Vol.50 (2), p.344-353

2015

Volltextzugriff (PDF)

Characterization of degradation products of Ivabradine by LC‐HR‐MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H 2 SO 4 acid hydrolysis

Journal of mass spectrometry., 2015-02, Vol.50 (2), p.344-353

2015

Volltextzugriff (PDF)

3D-QSAR and molecular docking studies of amino-pyrimidine derivatives as PknB inhibitors

Journal of the Taiwan Institute of Chemical Engineers, 2014-03, Vol.45 (2), p.354-364

2014

Volltextzugriff (PDF)

Neuroprotective Potential of Peroxisome Proliferator Activated Receptor-[alpha] Agonist in Cognitive Impairment in Parkinson's Disease: Behavioral, Biochemical, and PBPK Profile

PPAR research, 2014-01, Vol.2014

2014

Volltextzugriff (PDF)

Structure-Based Virtual Screening and Molecular Dynamic Simulation Studies to Identify Novel Cytochrome bc1 Inhibitors as Antimalarial Agents

Journal of Computational Medicine (Hindawi), 2013-08, Vol.2013 (2013), p.1-9

2013

Volltextzugriff (PDF)

Structure based de novo design of IspD inhibitors as anti-tubercular agents

Nature precedings, 2012-04

2012

Volltextzugriff (PDF)

Overview and Recent Advances in QSAR Studies

Chemometrics Applications and Research, 2016, p.29-60

2016

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(23)
Buchkapitel
(1)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oral delivery of anticancer drugs: Challenges and opportunities

A PPAR-β/δ agonist is neuroprotective and decreases cognitive impairment in a rodent model of Parkinson's disease

p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies

Neuroprotective Potential of Peroxisome Proliferator Activated Receptor-α Agonist in Cognitive Impairment in Parkinson's Disease: Behavioral, Biochemical, and PBPK Profile

Oleanolic acid analogs as NO, TNF-α and IL-1β inhibitors: Synthesis, biological evaluation and docking studies

Characterization of degradation products of Ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis

Leucine-684: A conserved residue of an AMP-acetyl CoA synthetase (AceCS) from Leishmania donovani is involved in substrate recognition, catalysis and acetylation

A combined ligand and structure based approach to design potent PPAR-alpha agonists

Effect of Different “States” of Sorbed Water on Amorphous Celecoxib

A combined pharmacophore modeling, 3D-QSAR and molecular docking study of substituted bicyclo-[3.3.0]oct-2-enes as liver receptor homolog-1 (LRH-1) agonists

Identification of p38α MAP kinase inhibitors by pharmacophore based virtual screening

Biological evaluation and structural insights for design of subtype-selective peroxisome proliferator activated receptor-α (PPAR-α) agonists

Antiplasmodial activity of short peptide-based compounds

Identification of dual Acetyl-CoA carboxylases 1 and 2 inhibitors by pharmacophore based virtual screening and molecular docking approach

Structure based virtual screening to identify selective phosphodiesterase 4B inhibitors

IPAT: a freely accessible software tool for analyzing multiple patent documents with inbuilt landscape visualizer

3D QSAR pharmacophore-based virtual screening and molecular docking studies to identify novel matrix metalloproteinase 12 inhibitors

Characterization of degradation products of Ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H sub(2)SO sub(4) acid hydrolysis

Characterization of degradation products of Ivabradine by LC‐HR‐MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H 2 SO 4 acid hydrolysis

3D-QSAR and molecular docking studies of amino-pyrimidine derivatives as PknB inhibitors

Neuroprotective Potential of Peroxisome Proliferator Activated Receptor-[alpha] Agonist in Cognitive Impairment in Parkinson's Disease: Behavioral, Biochemical, and PBPK Profile

Structure-Based Virtual Screening and Molecular Dynamic Simulation Studies to Identify Novel Cytochrome bc1 Inhibitors as Antimalarial Agents

Structure based de novo design of IspD inhibitors as anti-tubercular agents

Overview and Recent Advances in QSAR Studies

Suchergebnisse filtern